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3. RESUMEN/ABSTRACT 
Título: La reacción de hipersensibilidad tipo I en la especie canina: Dermatitis Atópica Canina y 
otras enfermedades alérgicas  
La reacción de hipersensibilidad tipo I (hipersensibilidad inmediata) es una reacción inmediata 
que se produce cuando un antígeno se combina con un anticuerpo (IgE) preformado (creado 
por una exposición sensibilizante al mismo antígeno) y se une a los mastocitos provocando una 
reacción instantánea: sustancias inflamatorias y vasoactivas son liberadas por esas células, 
causando vasodilatación, edema, quimiotaxis eosinofílica, prurito y broncoconstricción. Los 
ejemplos más importantes de reacciones de hipersensibilidad inmediatas en medicina 
veterinaria van desde trastornos alérgicos sistémicos (anafilaxis) hasta trastornos alérgicos 
específicos tales como alergias respiratorias y oculares (rinitis alérgica, bronquitis y 
conjuntivitis), alergias alimentarias y alergias cutáneas. Los trastornos alérgicos de la piel son 
los más relevantes en la especie canina, especialmente un síndrome multifactorial 
denominado Dermatitis Atópica Canina, sufrido por entre el 10 y el 15% de la población 
canina. En la primera década del siglo XX, el científico austriaco Clemens von Pirquet introdujo 
el término "alergia" en el mundo de la medicina humana. Posteriormente el concepto se 
extendió al campo veterinario y ya en 1941 se informó de un caso de manifestaciones clínicas 
compatibles con atopia canina en un perro afectado de rinitis alérgica estacional. Justo en 
1971 se describieron inicialmente los signos clínicos de CAD. Las condiciones alérgicas suelen 
ser multifactoriales y en ellas intervienen tanto factores intrínsecos, únicos del animal, como 
factores extrínsecos, relacionados con el medio ambiente y con el microambiente cutáneo. 
Una comprensión completa de estos factores es necesaria si la condición se quiere abordar  
con éxito desde el punto de vista diagnóstico y terapéutico.  
Palabras clave: alergia; hipersensibilidad; atopía; alérgeno; dermatitis atópica canina; CAD; 
alergia alimentaria; alergias respiratorias; alergia ocular  
Title: Type I Hypersensitivity reaction in the canine species: Canine Atopic Dermatitis and other 
allergic diseases  
Type I Hypersensitivity reaction (immediate hypersensitivity) is an immediate reaction that 
occurs when antigen combines with preformed antibody (IgE) (created by a sensitizing 
exposure to the antigen) that is attached to mast cells triggering an instant reaction: 
inflammatory and vasoactive substances are released from mast cells granules, causing 
vasodilatation, oedema, eosinophil chemotaxis, pruritus and bronchoconstriction. Important 
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examples in veterinary Medicine of Immediate Hypersensitivity reactions include from 
systemic allergic disorders (anaphylaxis) to specific allergic disorders such as respiratory and 
ocular allergies (allergic rhinitis, bronchitis and conjunctivitis) and food and skin allergies. Skin 
allergic disorders are the most relevant in dogs, including a multifactorial syndrome suffered 
from 10 to 15% of dogs named Canine Atopic Dermatitis (CAD). In the first decade of the 20th 
century the Austrian scientist Clemens von Pirquet introduced the term 'allergy' into the world 
of human medicine. Later the concept was extended to the veterinary field and in 1941 clinical 
manifestations of canine atopy first were reported in a dog affected with seasonal allergic 
rhinitis. It is only in 1971 that the clinical signs of CAD initially were described. Allergic 
conditions usually are multifactorial involving both intrinsic factors, unique to the animal, and 
extrinsic factors, relating to both the environment and cutaneous microenvironment. A 
thorough understanding of these factors is needed if the condition wants to be managed 
successfully via current diagnostic and therapeutic tools.  
Key words: allergy; hypersensitivity; Type I Hypersensitivity; atopy; allergen; atopic dermatitis 
syndrome; CAD; food allergy; respiratory allergies; ocular allergies  
4. INTRODUCTION AND JUSTIFICATION  
4.1. Introduction: Establishment and use of the concept of “allergy” and other terms  
Allergies, also known as allergic diseases, are a number of conditions caused by 
hypersensitivity of the immune system (Type I Hypersensitivity) to something in the 
environment that usually causes little or no problem in most animals and people (McConnell, 
2007). In the canine species, these conditions include systemic disorders (anaphylaxis) and 
specific disorders such as respiratory and ocular allergies (allergic rhinitis, bronchitis and 
conjunctivitis), food hypersensitivities and skin allergies. Currently, allergies are common both 
in people and dogs and cats (Guaguere, et al., 2008). However, allergies exist in all animal 
species (Miller & Willemse, 1997). As in human, the first case reports published, although 
anecdotal, were to foods. In 1941, a case of allergy was reported on a dog with recurrent 
seasonal pruritus that coincided with the ragweed season (Wittich, 1941) but it is only in 1971 
when the clinical signs of Canine Atopic Dermatitis (CAD) initially were described (Guaguere, et 
al., 2008). Despite these later discoveries, the term allergy was initially introduced in 1906 by 
the Viennese paediatrician Clemens von Pirquet.  
In dogs, the most relevant skin allergic disease is Canine Atopic Dermatitis (CAD). The 
incidence of CAD is still unknown, though some authors cite an incidence of 10-15% of the 
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canine population (Tizard, 2009). CAD is a common chronic pruritic dermatitis of the face and 
limbs, responsive to glucocorticoids and linked to a predisposition to develop allergic reactions 
to environmental allergens (Guaguere, et al., 2008). The terms atopic dermatitis and allergic 
dermatitis should not be used interchangeably. Allergic dermatitis is a form of dermatitis (also 
called eczema) characterized by spontaneous and occasional onsets of pruritus and hives on 
the skin in response to an allergen. In contrast, the concept of atopic dermatitis goes further. 
Atopic Dermatitis is typically a more specific set of associated conditions occurring in the same 
animal including chronic eczematous skin disease and a predisposition to develop other type of 
allergies (atopy) (Cole, 2016).   
In addition to the confusion between the terms atopic dermatitis and allergic dermatitis, there 
are other concepts that should not be confused in any case when talking about veterinary 
allergology (Olivry, et al., 2001; Guaguere, et al., 2008; Regueiro González, et al., 2010):  
- Hypersensivity: reproducible clinical signs, triggered by exposure to a stimulus which, at 
the same dose, produces no effect in a normal individual.  
- Allergen: an antigen that favours the development of a hypersensitivity response  
- Allergy: hypersensivity of immunological origin. A disease state characterized by 
hypersensitivity responses to allergens and oftentimes mediated by IgE antibodies.  
- Atopy (atopy state): predisposition to develop allergic reactions. It is the tendency to 
develop IgE-mediated allergy to environmental allergens.  
- Atopic disease: any clinical manifestation of atopy. In the dog, atopic dermatitis is the 
most commonly diagnosed atopic disease. Other poorly defined and uncommon atopic 
diseases of dogs include atopic conjunctivitis, atopic rhinitis and experimental atopic 
asthma. An atopic individual is a patient who suffers from an atopic disease.  
- Atopic dermatitis (AD): a genetically-predisposed inflammatory and pruritic allergic skin 
disease characterized by particular patterns of lesion distribution and frequent association 
with allergy to aeroallergens. Canine Atopic Dermatitis (CAD) is a classic example in the 
dog. 
4.2. Justification 
This literature review aims to detail the most important aspects related to nosography 
(description of the disease: aetiology, pathogenesis, nosobiotic, semiotics and nosognosis 
(clinical trials such as diagnosis and treatment, and their sources, types and tools) of the 
immune system disorders related to the process of Type I Hypersensitivity, allergy and atopy, 
paying particular attention to the condition on the dog (due to the enormous importance of 
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these conditions in canine species). This task seeks to clarify different key points used during 
the clinical approach of these conditions and to deepen in the study of immediate 
hypersensitivities, justifying the importance of all factors involved in the allergic condition, 
with special emphasis on those involved in Canine Atopic Dermatitis.  
5. OBJECTIVES 
Then, once the subject has been introduced and justified, the goals of the present review can 
be summarized with the following points: 
- To gain background knowledge of the Type I Hypersensitivity reaction 
- To identify potential areas and hypothesis for research in the field of allergology  
- To make a classification scientifically based of the main allergic diseases of the dog 
- To identify tested and potential tools for the diagnosis and treatment of allergic 
conditions  
6. METHODOLOGY 
The theoretical framework of this literature review is based on the collection of information 
related to the physiopathological and clinical study of those diseases of the immune system 
connected to the process of hypersensitivity, allergic reaction and atopy in domestic animals, 
valuing especially that scientific contribution coming from studies realized in the dog. The 
search for scientific literature related to the topic has been carried out in an inductive way. 
First it has been revised all the information focused on a theoretical point of view coming from 
great works created by current specialists in Immunology, Internal Medicine and Dermatology 
such as Ian R. Tizard, José Ramón Regueiro González-Barros and Eric Guaguere. Then, in order 
to enrich the theoretical part of the review, a rigorous search of current articles has been done 
using databases such as the Nation Centre for Biotechnology Information (NCBI) and 
Scholar/Academic Google.   
The review also includes a real clinical perspective with the presentation of cases collected in 
two veterinary practices: the Department of Dermatology of the Veterinary Hospital of Ghent 
University (Faculteit Diergeneeskunde) and EMVET Emergencias Veterinarias de Zaragoza. 
These clinical cases have been addressed first-hand during the period from September 2016 to 
June 2017. The presentation of these subjects aims to exemplify some theoretical references 
cited during the writing of this review.   
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7. RESULTS AND DISCUSSION 
7.1. Classification of Immune Disease: Hypersensivity reactions 
Immune-mediated disorders occur when the protective immune response is activated 
inappropriately, resulting in organ injury. Pathologic immune reactions may occur in response 
to infectious pathogens and contribute to the clinical disease presentation for that pathogen 
or be stimulated by otherwise innocuous foreign substances (allergens) or by self-antigens 
(Nelson & Couto, 2014). Even though there is no completely satisfactory system for 
categorizing immune disease, the big picture can be described by the proposal of Gell and 
Robin Coombs (1963) that is still the basis for our understanding of most allergic disorders 
(Miller & Willemse, 1997; Rajan, 2003). Gell and Robin Coombs classified the hypersensitivity 
reactions into four groups (Table 1) on the basis of every hypersensitivity reaction (whether an 
allergy on autoimmune disease) involves one of four basic immune mechanisms (McConnell, 
2007). This classification helps in the understanding of the immunology of allergy (Types I and 
IV) and immune mediated diseases (Types II and III).  
Table 1. Gell and Coombs classification of hypersensitivity: mechanisms of immunopathologic injury   (Miller & 
Willemse, 1997; McConnell, 2007; Nelson & Couto, 2014) 
TYPE IMMUNE SYSTEM 
EFFECTORS 
MECHANISMS EXAMPLES 
B-cell reactions  
Type I, immediate 
hypersensitivity 
(allergic reaction*)  
Humoral immune system 
(T-helper cells, B cells), 
IgE, mast cells, 
inflammatory mediators  
IgE-mediated degranulation 
of mast cells following 
antigen binding and cross-
linking of IgE 
Acute anaphylactic 
reactions, atopy, allergic 
bronchitis, food allergies 
Type II, cytotoxic 
hypersensitivity 
Humoral immune system, 
IgG and IgM 
IgM/IgG antibody antigen 
interactions on target cell 
surfaces 
Immune-mediated 
haemolytic anaemia, 
immune-mediated 
thrombocytopenia, 
myasthenia gravis, 
pemphigus foliaceus  
Type III, immune 
complex 
hypersensitivity 
Soluble immune 
complexes 
Immune complex formation 
and deposition in tissues 
leading to local or systemic 
inflammatory reactions  
Glomerulonephritis, 
systemic lupus 
erythematosus, 
rheumatoid arthritis 
T-cell reactions 
Type IV, cellular 
(delayed) 
hypersensitivity  
Sensitized T lymphocytes, 
cytokines, neutrophils, 
and macrophages  
Sensitized TH1 cells 
activated to release 
cytokines upon binding to 
antigen, resulting in 
macrophage and cytotoxic 
T cell accumulation  
Lymphocytic thyroiditis, 
myositis, contact 
dermatitis, chronic 
transplant rejection  
* The majority of authors when discussing allergies only refer to Type I Hypersensitivity.  However, Type IV 
hypersensitivity must also be present since cellular hypersensitivity can also produce allergic pictures; animals do 
not always respond to allergens of arthropods with a type I hypersensitivity, for example, the response to Demodex 
mites and to components of flea saliva may be cell-mediated (Type IV hypersensitivity) (Tizard, 2009).  
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7.2. Mechanisms, cellular and molecular components of Type I Hypersensitivity 
reaction  
Once the general aspects of immune disorders and different types of hypersensivity have been 
presented, the attention will be focused in Type I Hypersensitivity reaction, which is the main 
responsible of allergies.  
Most individuals constantly inhale certain allergens (e.g. pollen) without an immune response 
or, in any case, small amounts of IgG are produced against the inhaled allergen. However, as 
was said in the introduction, certain individuals, called atopic patients, have a genetic 
tendency to develop intense IgE-mediated responses (Type I Hypersensitivity reaction) against 
these allergens. Multiple molecular and cellular components take place in the mechanisms by 
which this excessive production of IgE is generated.  
IMMUNOLOGICAL MECHANISMS  
Type I Hypersensitivity reaction depends on the production of IgE antibodies against a certain 
allergen and the consequent activation of the mast cells sensitized to these IgE. These certain 
allergens have no common pattern, except that they are usually low molecular weight 
glycoproteins that diffuse easily through skin and mucous membranes (Regueiro González, et 
al., 2010).  
In the mechanisms described for the Type I hypersensitivity reaction, two stages can be 
distinguished: 
- Sensitization stage 
- Re-exposure or elicitation stage  (followed by a delayed reaction) 
The sensitization stage occurs the first time that an individual comes in contact with these 
allergens (Randall, 2005). Allergens that are inhaled or pass through the skin or mucous 
membranes are picked up by the antigen-presenting cells, mainly the Langerhans cells, which 
transport them to the lymph nodes where allergens are presented to Th2 cells through Class II 
Major Histocompatibility Complex (MHC II). Th2 cells promote the proliferation and 
differentiation of allergen-specific B cells and stimulating cytokine secretion, mainly IL-4 and IL-
13, what favour their change from isotype to IgE-producing cells. The result of the sensitization 
phase is therefore the production of specific IgE that will bind to the high affinity FcεRI 
receptor on the surface of the mast cells which are located below the skin and mucous 
membranes and associated with blood vessels.  
 . 
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The sensitization phase does not produce any clinical signs, but if a previously sensitized 
individual is re-exposed to the same allergen (re-exposure or elicitation stage), its recognition 
by IgE will cause the mast cells degranulation producing an immediate inflammatory reaction 
(in a few seconds or minutes). The immediate reaction depends fundamentally on the 
secretion of vasoactive molecules preformed and stored in the granules of mast cells such as 
histamine and tryptase, and lipid mediators derived from its membrane such as leukotrienes, 
prostaglandins and platelet activating factor. Their release produces a rapid increase in local 
blood flow, increased vascular permeability, and smooth muscle contraction. This response is 
identical to that which produces an infection, and is intended to recruit elements of the 
immune response to the site of inflammation. The contraction of the smooth muscle attempts 
to expel the pathogen, in this case from the allergen, and its manifestations range from mucus 
secretion (by contraction of the smooth musculature of the mucous glands) to cough, vomiting 
or diarrhoea.  
The elicitation stage is followed by a delayed reaction (with a peak at 6-12 hours) more or less 
intense depending on the amount of allergen and the degree of sensitization. The late reaction 
is induced by the synthesis of new mast cell inflammatory mediators (prostaglandins, 
leukotrienes and platelet activating factor) that produces their biological effect over the 
following hours. Also due to the production of chemokines and cytokines such as IL-4, IL-5, IL-
9, IL-13, TNF-ɑ, etc., the inflammatory reaction is prolonged, eosinophils are recruited, and 
vasoactive molecules are secreted what produce the late damage and mucus production, 
oedema, skin redness and pruritus associated with allergic reactions (Tizard, 2009; Regueiro 
González, et al., 2010). 
The mechanism by which atopic dermatitis (AD) (in our case, Canine Atopic Dermatitis) 
develops is similar to other allergic processes (Randall, 2005).  However, some aspects of this 
multifactorial disease should be especially mentioned such as the role of cytokine IL-31 and 
the JAK-STAT pathway. IL-31 is a recently described cytokine that plays an important role in 
CAD and the pruritus cycle (chronic itching is one of the most important and distressing 
features of atopic skin disease).  It is detected in more than 50% of dogs with DAC, but not in 
dogs with other inflammatory diseases (Artola Magallon & Verde Arribas, 2016). In atopic 
dermatitis, when a dendritic cell (such as Langerhans cells) is exposed to the same allergen and 
T-cell activation is triggered rapidly, pruritogenic cytokines such as IL-31 are also released 
(Tizard, 2013). IL-31 travels and binds to receptors found on the surface of neurons. This 
interaction leads to the activation of Janus Kinase (JAK) enzymes, which stimulates the 
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transmission of the signal along the nerve to the brain, promoting pruritus. The JAK-STAT 
(Janus kinase/signal transducer and activator of transcription) pathway has been shown to play 
an essential role in the dysregulation of immune responses in atopic dermatitis, including the 
exaggeration of Th2 cell response, the activation of eosinophils, the maturation of B cells, and 
the suppression of regulatory T cells. In addition, the JAK-STAT pathway, activated by IL-4, also 
plays a critical role in the pathogenesis of atopic dermatitis by upregulating epidermal 
chemokines, pro-inflammatory cytokines, and pro-angiogenic factors as well as by 
downregulating antimicrobial peptides (AMPs) and factors responsible for skin barrier function 
(Bao, et al., 2013).  
IMMUNOLOGICAL COMPONENTS 
Once the mechanism is exposed, a more detailed description of the cellular and molecular 
agents involved in the reaction is almost essential in the understanding of the immediate 
immunity.  
IMMUNOGLOBULIN E  
IgE is an immunoglobulin with a conventional four chain structure, with a molecular weight of 
about 200 kDa. It is found in serum in extremely low amounts (9 to 700μg / ml in dogs), and its 
half-life is only 2 days. Most of the IgE in the body is not localized in the bloodstream, but is 
tightly bound to Fcε receptors on mast cells, where it has a half-life of 11-12 days (Tizard, 
2013). IgE production is initiated when Th2 lymphocytes generate interleukins 4 (IL-4) and 
interleukins 13 (IL-13). Atopic individuals are predisposed to generate Th2 lymphocytes that 
produce these compounds. These cytokines, together with the stimulation of the Cluster of 
Differentiation 40 (CD40), initiate the synthesis of IgE by B lymphocytes. B lymphocytes start 
with an IgM molecule on its surface that is specific for the antigen. Then, T helper (Th2) cells 
assist B cells in making antibody by producing cytokines (IL-4) that are partially responsible for 
causing the isotype switch from IgM to IgE.  
Once formed, IgE seeks to bind to either the inciting allergen or to IgE receptors located on a 
variety of cell types (e.g. mast cells) (UTHealth, 2008). Mast cells have high affinity IgE 
receptors and once stimulated, they produce IL-4 in important amounts. This may alter the 
helper cell balance and enhance yet more Th2 cell production and IL-4 release (Tizard, 2009). 
Therefore, the whole mechanism of IgE production is destined to ensure its survival and 
maintenance during the response.  
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MAST CELLS  
When IgE binds to Fcε on the surface of mast cells, it does not have an immediate evident 
effect on the cell. However, if an antigen enters the tissue a second time, finds the mast cell 
and cross-links two of fixed IgE molecules on the surface of the cell, the mast cell will be 
activated to remove the contents of its secretory lysosomes and their inflammatory mediators 
to the surrounding tissues (Tizard, 2009). This rapid activation of exocytosis begins when an 
antigen molecule cross-links two mast cell receptors and activates several tyrosine kinases 
which, in turn, activate phospholipase C, which causes the production of diacylglycerol and 
inositol triphosphate. These mediators elevate intracellular calcium and activate more protein 
kinases that phosphorylate the myosin in the cytoskeleton, causing the migration of the 
secretory lysosomes to the cell surface, fusing their membranes with cell-membrane 
phospholipids, and releasing their contents into the extracellular fluid. The cross-link of two IgE 
mast cell receptors by the antigen also activates phospholipase A, which acts on membrane 
phospholipids to produce arachidonic acid. Subsequently, other enzymes convert arachidonic 
acid into leukotrienes and prostaglandins. Finally, protein kinases promote the transcription 
and expression of the genes encoding many different cytokines, as well as the genes for 
cyclooxygenase and lipoxygenase (Hill & Martin, 1998).  
EOSINOPHILS 
One characteristic of tissues suffering from Type I Hypersensitivity reactions is the presence of 
large numbers of eosinophils. These cells are attracted to the degranulation sites of mast cells, 
where they also degranulate and release their own biologically active molecules. Eosinophils 
can be considered as the ultimate effector cells of the allergic reaction, so probably they are 
the main responsible of the delayed stage of an allergic reaction. 
Several mechanisms are involved in the mobilization of eosinophils. One of the most important 
is produced by Th2 lymphocytes and mast cells, which produce IL-5 and chemokines, known as 
eotaxins that stimulate eosinophil output from the bone marrow. Once eosinophils reach the 
degranulation site of mast cells, they increase their ability to eliminate parasites, a fact that 
supports the theory that the main function of IgE-mediated responses is the control of 
helminth parasites. Mast cells and eosinophils interact extensively in allergic reactions (Tizard, 
2009) and it is clear that on balance, eosinophils exacerbate the inflammation triggered by 
mast cells (Tizard, 2013).  
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SOLUBLE MEDIATORS  
The soluble mediators released from degranulating mast cells, eosinophils and also basophils 
release a complex array of molecules that contribute to the acute inflammatory process and it 
will mainly characterize the clinical picture of Type I Hypersensitivity reactions which will be 
described later.  
Soluble mediators from degranulation of mast cells can be found at high levels in tissue fluids 
during allergic reactions and may be classified in three categories and: molecules released 
from exocytose granules (histamine, serotonin, tryptase, kallikreins, proteases and 
proteoglycans), lipids (ecosanoids) synthesized within minutes (leukotrienes, prostaglandins, 
platelet-activating factor), and proteins synthesized over several hours (IL-4, IL-5, IL-6, IL-13, 
TNF-ɑ, MIP-1ɑ) (Tizard, 2013).  
In addition to soluble mediators released from degranulating cell components, another 
cytokine of the IL-1 family plays an important role in inflammation and promotes Th2 
responses leading to allergies. This is the IL-33. It is produced by smooth muscle cells, epithelial 
cells, fibroblasts keratinocytes, dendritic cells, and activated macrophages. In the presence of 
IgE, IL-33 binds to a receptor on mast cells, basophils, and Th2 cells and produces the 
production of inflammatory cytokines. IL-33 is probably therefore a major mediator of Type I 
hypersensitivity (Tizard, 2013).  
Although the importance of mast cell degranulation, it has been seen that fatal allergic 
reactions can be induced in mast cell-deficient mice, possibly measured by platelets (Cara, et 
al., 2004). Analysis indicates that this is mediated by IgG acting through IgE receptors on 
platelets and neutrophils. Their role in allergies in other species is unclear (Cara, et al., 2004; 
Tizard, 2013).  
7.3. Factors involved in the onset of Type I Hypersensitivity reaction  
As has already been said, allergens and some immune mechanisms are the root causes of the 
allergic disorders. Although this is important, sometimes the condition is multifactorial 
involving both intrinsic factors unique to the animal, and extrinsic factors, relating to both the 
environment and cutaneous microenvironment (Guaguere, et al., 2008). These factors are 
extremely important when we talk about Canine Atopic Dermatitis and, therefore, we shall 
devote special attention to this disease. 
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Atopic dermatitis has a multifactorial, incompletely understood pathogenesis in both dogs and 
people. Until a few years ago, the traditional pathogenetic view of atopic dermatitis focused 
on the interpretation that it was due to genetic alterations of the immune system leading to 
abnormal immunological response (e.g. increased allergen-specific immunoglobulin E (IgE) to 
innocuous allergens (inside-outside theory). More recently, a theory focused on the 
fundamental role of the epidermal barrier has been proposed (outside-inside theory). The 
outside-inside theory proposed that an abnormal skin barrier in atopic patients facilitates the 
penetration of allergens (and microbes) though the epidermis, increasing their contact and 
exposure to epidermal immune cells (Wolf & Wolf, 2012). Such theories are not mutually 
exclusive and they have been integrated into a more comprehensive theory (outside-inside-
outside theory) based on the view that a primary defect in the epidermal barrier leads to a 
higher penetration of allergens and microbes that overstimulate the local immunity (innate 
and adaptive).  Such excessive stimulation triggers the release of inflammatory mediators that 
further exacerbate the barrier dysfunction (Santoro, et al., 2015).  
The following is a description of those factors involved in the allergic reaction. A thorough 
understanding of these factors is needed if the condition is to be managed successfully 
(Guaguere, et al., 2008).  
INTRINSIC FACTORS 
GENETIC PREDISPOSITION 
Studies involving lines of atopic dogs or dogs that have been artificially sensitised show that 
the allergen-specific IgE response, total IgE concentration and the clinical expressions of CAD 
depend on different genes. This suggests that in dogs, genetic predisposition to allergies is 
probably multiallelic (Sousa & Marsella, 2001; Guaguere, et al., 2008). However, genetics of 
atopy and allergy is complex: if both parents are atopic, most of their offspring will also be 
atopic and will suffer allergies, but if only one parent is atopic, the percentage of atopic 
offspring varies (Tizard, 2009).  
Genetic or breed predispositions to CAD are very significant in the dog.  Breeds commonly 
affected in America, Europe and Japan include Shar pei, Fox terrier, Jack Russel terrier, 
Labrador retriever, French bulldog, West Highland White terrier, Boxer and Dalmatian (Sousa 
& Marsella, 2001; Guaguere, et al., 2008). Cross breeds may also be affected. Additionally, not 
only the development of this disease but also its clinical phenotype vary between breeds; 
some breed may develop lesions in specific areas (e.g. French bulldog develop lesions in the 
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axillae, eyelids, and flexural surfaces, German Shepherds, in contrast, tend to develop lesions 
in the elbows, hind limbs, and thorax) (Wilhem, et al., 2011).  
In addition, there are some indications that the allergic status of parents, especially mothers, 
has a direct influence on the development of allergies in offspring. Fact which suggests that 
there is vertical transmission of allergies in dogs. The mechanisms of this effect are unknown, 
but it is possible that certain factors ingested with the colostrum of allergic mothers may 
favour the change towards a Th2 type response in their puppies (Barret, et al., 2003).  
IMMUNE RESPONSE  
Each atopic individual evokes an IgE immune response to environmental antigens. This 
abnormality is due to a deviation in the cellular immune response, thought to be a Th2 
response, characterized by production of cytokines that favour the allergic response: increased 
IgE production, expression of high-affinity receptors by antigen-presenting cells (Langerhans’ 
cells) and mast cell pre-activation. This creates a vicious circle perpetuating the allergic 
response. The IgE-laden antigen-presenting cells present a large quantity of epitopes to 
lymphocytes, favouring an IgE response. Pre-activated mast cells are very readily activated by 
immunological and non-immunological stimulation (Guaguere, et al., 2008).  
Many bacteria and viruses elicit a Th1-mediated immune response, which down-regulates Th2 
responses (Folkerts, et al., 2010). Thus, these types of microorganisms may be related in the 
modulation of the immune response, predisposing to the appearance of allergic diseases. The 
hygiene hypothesis was developed to explain this observation in a study which reveals that hay 
fever and eczema, both allergic diseases, were less common in children from larger families 
and individuals from the developing world, which were; it is presumed, exposed to more 
infectious agents through their siblings, than in children from families with only one child or 
individuals from the industrialized world (Gibson, et al., 2003). In the same field, studies in the 
third world demonstrate an increase in immunological disorders as a country grows more 
affluent and, it is presumed, cleaner (Addo-Yobo, et al., 2007). The use of antibiotics in the first 
year of life has also been linked to asthma and other allergic diseases (Marra, et al., 2006). The 
use of antibacterial cleaning products has been associated with higher incidence of asthma, as 
has birth by caesarean section rather than vaginal birth (Thavagnanam, et al., 2007; Zock & 
Plana, 2007). Although many aspects of the hygiene hypothesis have been extensively 
investigated by immunologists and epidemiologists and have become an important theoretical 
framework for the study of allergic disorders in humans (Gibson, et al., 2003), findings have 
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been found to show some differences in the canine species. It has been suggested that contact 
with allergens in the first days of life predisposes pups to develop significantly higher IgE levels 
than pups sensitized at 4 months of age. Additionally, normal animals infested by helminths 
and insects parasites also produce large amounts of IgE, so it is believed that the IgE response 
has evolved specifically to counteract these organisms. It is interesting to note that atopic and 
parasitized dogs may have reduced levels of IgA, an observation that supports the idea that IgA 
deficiency could presuppose a compensatory increase in IgE production (Tizard, 2009). 
SURFACE HYDROLIPID BARRIER AND KERATINISATION ABNORMALITIES  
In the atopic dog, surface hydrolipid barrier abnormalities lead to increased water loss and 
greater adherence of allergens and infectious agents such as staphylococci and Malassezia 
spp. In breed such as the West Highland White terrier and Shar pei, keratinisation disorders 
sometimes dominate the clinical picture (Guaguere, et al., 2008). 
In humans with atopic dermatitis (AD), the epidermal lipid barrier is abnormal because of 
combined insufficient extrusion of lipid-containing organelles into the superficial epidermal 
intracellular spaces as well as skin lipid metabolic defects. Studies investigating skin hydration 
and lipids in atopic dogs are scarce and unfortunately have yielded conflicting data. Whether 
or not dogs with AD exhibit dry skin and an inadequate stratum corneum barrier (Olivery & 
B.Hill, 2001).  
EXTRINSIC FACTORS 
Allergic individuals may overreact to a large number of different allergens, any antigen, most 
often eaten (food allergens) or inhaled (aeroallergens), that is recognized by the immune 
system and causes the allergic reaction (Guaguere, et al., 2008). The presence of these 
allergens in the environment and diet are considered as extrinsic factors. 
In addition to allergens, parasitic and infectious agents will often have a direct relationship 
with the pathogenesis and clinical course of some allergic conditions. Agents such as 
Ctenocephalides felis, Staphylococcus intermedius and Malassezia spp. have to be considered 
in the study of the clinical course of CAD. In fact, atopic dermatitis is the main cause of 
Malassezia dermatitis (Table 4) (Boer & Marsella, 2001; Guaguere, et al., 2008).  In the case of 
allergic bronchitis and allergic conjunctivitis, infectious agents will also act as complicating 
agents and should be considered during the clinical approach (King, 2004).  
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AEROALLERGENS 
In every continent, house dust mites are the most commonly encountered aeroallergens. The 
most allergenic in the dog is Dermatophagoides farinae. Sensitivities of other pyroglyphid 
mites, D. pteronyssinus and D. microcera, are a lot less common. The difference in sensitivity to 
that seen in the human population sharing the same habitat is probably explained by the fact 
that the major allergens in dogs and people are different. On the other hand, the incidence of 
forage mite sensitivity is also high in atopic dogs. It is difficult to know if this apparent 
sensitivity is due to cross reactivity with Dermatophagoides mites or a genuine sensitivity in its 
own right.  
The importance of allergies to hair and epithelia, human or animal, is unclear in dog. Cases of 
cockroach sensitivity have been reported in Europe. They have always been associated with 
pyroglyphid mite allergy and the inclusion of cockroach allergen in anti-allergen vaccines has 
never been found to worthwhile. The allergic pollens are, as in human medicine, anemophilous 
pollens. Mould spores are often incriminated. Linen, wool, cotton and kapok are now known to 
be non-allergenic in the dog (Guaguere, et al., 2008). 
FOOD ALLERGENS 
About 2% of ingested proteins are absorbed as peptide fragments large enough to be 
recognized as foreign. Foods most commonly incriminated in food hypersensitivity studies in 
the dog are meat (beef, chicken and lamb), egg, dairy products and soya, but any dietary 
protein is potentially allergenic (Martín, et al., 2004). The IgG is the main allergen in foods from 
ruminants (Jeffers, et al., 1991). Either of these antigens can be spread by the blood and reach 
the mast cells of the skin in a few minutes (Tizard, 2009).   
Food allergens are particularly important in the atopic dog. Through the establishment of an 
elimination diet in atopic dogs (in which hypoallergenic foods are administered) clinical signs 
are controlled in 30% of cases (Shaw, et al., 2004).  
7.4. Major allergic diseases in dogs: systemic and specific allergic disorders  
The route of entry (inhalation, food and blood), dose of the allergen and the sensitization 
status of the animal will determine the location and amount of cells that respond to the 
antigen and, in turn, the development of different forms of allergic reactions with a very varied 
symptomatology (Regueiro González, et al., 2010). As we already known, the clinical signs of 
Type I Hypersensitivity derive from the abrupt and excessive release of inflammatory 
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mediators by mast cells, eosinophils and basophils in response to the presence of an antigen 
(Tizard, 2009).  
Two large groups of allergic reactions can be established (Table 2). In the first place, those that 
are generated systematically and extensively in the animal (anaphylaxis) and secondly, those 
that tend to occur more localized in the individual.  
Table 2. Major allergic diseases in dogs: systemic and specific allergic disorders (Type I Hypersensitivity)  
CONDITION ORIGIN 
Systemic allergic disorder  
Anaphylaxis Aerosol exposure to antigens, blood 
inoculation, allergen ingestion  
Specific allergic disorder  
Eye allergies: 
allergic conjunctivitis and allergic blepharitis 
Aerosol exposure to antigens 
Respiratory allergies: 
allergic rhinitis and allergic bronchitis (asthma) 
Aerosol exposure to antigens  
Food allergies: 
gastrointestinal disorders (vomits and diarrhoea) and allergic 
dermatitis (urticarial) 
Allergen ingestion  
Skin allergies: 
allergic dermatitis, atopic dermatitis 
Allergen ingestion, aerosol exposure to 
antigens 
Allergy to drugs and vaccines Drug ingestion, antigen blood inoculation  
Allergy to parasites Exposure to parasites (e.g. helminths)  
Allergy to other organisms Exposure to other organisms (e.g. 
Thaumatopoea processionea) 
 
Despite the particularities of each allergic reaction, some may share similarities in the clinical 
picture. For example, urticaria, angioedema, and anaphylaxis all are Type I Hypersensitivity 
reactions and may occur in different allergies (i.e., a classic example of the appearance of 
urticarial is in allergic dermatitis, however, food allergies can also produce this injury). 
Urticarial lesions are focal and superficial reactions where wheals (hives) develop on the skin 
(Fragio, 2011). Lesions may be single or multiple and may affect the whole body. Angioedema 
reactions can be thought of as deep wheals. Deep blood vessels are affected and the oedema 
causes diffuse swelling, typically of one area such as the head (Figure 1). If the clinical picture 
manifested in the form of urticaria or angioedema evolves to a more severe form, the 
anaphylactic reaction will appear (Miller & Willemse, 1997).  
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Figure 1. On the left: Boxer, non-neutered female, 4 years old:  evident swelling face due to angioedema. On the 
right: Bumps visible in the same dog as a consequence of hypersensitivity reaction. The signs of allergy suddenly 
appear (5 minutes) after a routing walk through a park with abundant floral gardens. No ingestion of any allergic 
component is suspected (Emergencias Veterinarias de Zaragoza EMVET, Zaragoza-Spain, 2017).  
 
SYSTEMIC ALLERGIC DISORDERS 
ANAPHYLAXIS 
Anaphylaxis or anaphylactic reaction is an especially severe type I reaction that results in 
immediate and widespread release of inflammatory and vasoactive substances from mast 
cells, provoking widespread vasodilatation and oedema. Vasodilatation causes flushing, low 
blood pressure, and fainting or shock, and accumulation of oedema that can produce airway 
obstruction. In some cases smooth muscle spasm can occur and cause severe bronchial 
restriction (bronchospasm). Death can occur because of vascular collapse or to asphyxiation 
from laryngeal oedema or bronchospasm (McConnell, 2007).  
The clinical signs of anaphylaxis are determined by the organic system involved. Dogs differ 
from other domestic animals in that the main organ affected is not the lung but the liver, 
especially the hepatic veins. Dogs suffering from allergic anaphylaxis show initial excitement 
followed by vomiting, defecation, and urination. As the reaction progresses, the dog collapses, 
with muscle weakness and respiratory depression, goes into coma and convulsions, and dies in 
about an hour. At necropsy, the liver and intestine are very dilated, containing up to 60% of 
the animal's total blood (visceral haemorrhage). These signs come from occlusion of the 
hepatic vein due to the combination of smooth muscle contraction and hepatic oedema, which 
leads to hypertension and visceral oedema, in addition to a decrease in venous return, cardiac 
output and blood pressure. The mediators identified are histamine, prostaglandins and 
leukotrienes (Tizard, 2009). Acute hepatic venous congestion may result in swelling of the 
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gallbladder wall and thus the sonographic creation of the gallbladder halo sign (Figure 2). 
However, there many other causes of gallbladder wall oedema (pancreatitis, cholecystitis, 
pericardial effusion, etc.) (Lisciandro, 2016) .  
 
Figure 2. Ultrasonographic image (within minutes 
of patient arrival) of the gallbladder in a Pug, non-
castrated male, 4 years old, with classic clinical 
signs of hypovolemic shock compatible with an 
acute allergic reaction:  decrease in venous return, 
low blood pressure and pale mucous. Note the 
gallbladder wall oedema referred to as the 
“Gallbladder Halo Sign”. In the same examination, 
the intestines are very dilated, containing large 
amounts of blood (Emergencias Veterinarias de 
Zaragoza EMVET, Zaragoza-Spain, 2017). 
 
SPECIFIC ALLERGIC DISORDERS 
EYE ALLERGIES 
Type I hypersensitivity reactions located in the eye are usually caused by exposure of small 
doses of allergen in aerosol in atopic animals.  
Allergic conjunctivitis  
Allergic conjunctivitis occurs when the conjunctiva, the clear membrane covering the white 
part of the eye, comes in contact with an allergen. This phenomenon produces inflammation 
and intense tearing. Several causes can produce conjunctivitis (infectious agents, viruses, 
parasites, systemic infections) but the allergic component is common and usually originates in 
atopy (Morgan, 2008; Lourenço-Martins, et al., 2011) 
Allergic blepharitis 
Allergic blepharitis is the inflammation of the eyelids due to a reaction that an allergen triggers 
when contacts with eyelids, Meibomian glands and the glands of Zeis and Moll. As in the case 
mentioned above, different causes can also produce blepharitis but atopy, contact allergies 
(Type IV hypersensitivity) and food hypersensitivity are common immune-mediated disorders 
that can cause this inflammation (Morgan, 2008).  
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RESPIRATORY ALLERGIES 
Allergic rhinitis and bronchitis  
Type I hypersensitivity reactions located in the airways are usually caused by inhalation of 
small doses of allergen in aerosol (pollen, mites...). If the inhaled allergen comes into contact 
with the nasal mucosa it causes spring allergic rhinitis or hay fever in people, characterized by 
sneezing, nasal mucus, itching, etc., which is produced by degranulation of the mast cells of 
the nasal and upper airways mucosa (Regueiro González, et al., 2010). Allergic rhinitis is an 
unusual or an underdiagnosed condition in dogs (King, 2004; Tizard, 2013). 
When the allergen penetrates into lower airways produces a more severe syndrome called 
allergic asthma. The contraction of the smooth muscles of the lower airways and the 
exaggerated secretion of mucus in the bronchial cavities can compromise breathing. An 
inevitable consequence of chronic asthma is the hyperreactivity of the airways to nonspecific 
agents (cold, pollution, exercise, etc.), which perpetuate the inflammatory reaction even in the 
absence of a re-exposure of the allergen; consequently the discrimination what is the cause of 
this type of reactions is very difficult (Regueiro González, et al., 2010). Individuals of the canine 
species can also develop a kind of ‘asthma’, duly called Chronic Bronchitis. However, the 
pathophysiology of this disease is even more unexplained than in humans and cats. In fact, this 
condition in dogs should not be called asthma because the aetiology is not only allergic, but 
different possible causes trigger bronchitis in dogs: atmospheric pollution, passive smoking, 
respiratory tract infections, genetic or acquired defects and hypersensivity (allergic) lung 
diseases (King, 2004; Morgan, 2008). When the main cause is an allergic reaction to something 
in the environment, the disorder can be named allergic bronchitis (Bright, 2011).  Whatever 
the cause, the most common functional sequela of chronic bronchitis is chronic airflow 
obstruction, which is generally referred to as chronic obstructive pulmonary disease (COPD).  
Although chronic bronchitis is common in dogs, especially in smaller breed dogs in middle age 
to older (age greater than 5 years) (King, 2004), allergic causes are less likely. However, Basenji 
dogs have extremely sensitive airways and suffer from a disease similar to that of people with 
asthma (Tizard, 2009).   
FOOD ALLERGIES  
Many different names are used to describe adverse reactions to foods, including food 
intolerance and food allergy. It is important not confuse these concepts. Food allergy is a 
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reaction caused by the immune system’s reactions to a food, causing distressing and often 
severe symptoms. On the other hand, food intolerance does not involve the immune system 
but its mechanism includes metabolic reactions and food idiosyncrasies (Homeier, 2005). 
In the present case of food allergies, when the allergen is ingested, the degranulation of the 
mast cells of the intestinal mucosa produce vomiting and diarrhoea. If allergens are absorbed 
through the intestinal mucosa and pass into blood they can trigger the degranulation of the 
mast cells of the subcutaneous connective tissue, resulting in urticaria (Regueiro González, et 
al., 2010). Therefore, clinical consequences of food allergies are seen both in digestive tract 
and on the skin.  
It is claimed that up to 30% of skin diseases are due to allergic dermatitis, and that reactions to 
allergens ingested account for up to 1% of skin diseases in dogs and cats, although the actual 
prevalence is unknown. Between 10 and 15% of dogs with food allergies have gastrointestinal 
disorders. The intestinal reaction may be moderate, manifesting only as an irregularity in the 
consistency of the faeces, or it may be severe, with vomiting, colic and intense diarrhoea, 
sometimes haemorrhagic, occurring soon after eating. At least half of these affected dogs have 
non-seasonal and non-sensitive to corticosteroids pruritic dermatitis, usually popular and 
erythematous and can affect legs, eyes, ears, armpits and perineal area. In chronic cases the 
skin may be hyperpigmentated, with lichenification and infection, leading to pyoderma. 
Chronic pruritic otitis can also develop (Jeffers, et al., 1991; Tizard, 2009).  
SKIN ALLERGIES  
Allergic dermatitis  
Allergic dermatitis is a type of cutaneous eczema that manifests as a skin lesion characterized 
by the appearance of lesions called allergic-type skin rashes and intense pruritus. It is a kind of 
allergy that arises in response to one or more allergens both of environmental origin or food 
precedence. 
Atopic Dermatitis (Canine Atopic Dermatitis) 
As we have already said on several times in previous points, atopic dermatitis, termed in the 
dog as Canine Atopic Dermatitis (CAD) is a common chronic multifactorial syndrome that is 
characterized by a skin with inflammation and chronic pruritus of the face and limbs, 
responsive to glucocorticoids (Table 4) and linked to a predisposition to develop allergic 
reactions to environmental allergens (Figure 3) (Guaguere, et al., 2008). Although it is not 
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known with certainty the percentage of the canine population that suffers from the disease, it 
is estimated that between 10 and 15% of dogs are affected. 
  
Figure 3. On the left: atopic dermatitis in a Shar Pei: muzzle and periorbital erythema and excoriations around the 
lips. On the right: the same dog after a shaving and spreading a gel over the area being tested by an abdominal 
ultrasound. The appearance of urticaria in a skin predisposed to react to any stimuli can be seen (Emergencias 
Veterinarias de Zaragoza EMVET, Zaragoza-Spain, 2017).  
 
Lesions that are generated due to the atopic dermatitis are secondary to pruritus and range 
from acute erythema and oedema to more chronic secondary changes such as crusting, 
scaling, hyperpigmentation, lichenification and secondary infections (Malassezia spp.). Some 
animals may present external otitis or conjunctivitis as a consequence of atopic dermatitis 
(Tizard, 2009) 
Canine atopic dermatitis includes hypersensitivity to both environmental antigens and food 
antigens and produces lesions that will often be identical to those produced in chronic cases of 
allergic dermatitis or food allergies. For this reason, it is impossible to distinguish atopic 
dermatitis causes by food allergens from atopic dermatitis caused by aeroallergens. When 
there is no demonstrable evidence of allergy, or more precisely, atopy, despite a clinical 
history consistent with this condition, the term “atopic dermatitis-like” is sometimes used. The 
multiplicity of clinical forms and causes of CAD is such that today in human medicine, the term 
“atopic dermatitis syndrome” is used. Such variety also exists in the dog and we have chosen 
to use the term canine atopic dermatitis syndrome (Guaguere, et al., 2008).  
OTHER ALLERGIC REACTIONS 
Allergy to vaccines and drugs  
If the allergen is given intravenously (a drug, for example), they can be distributed throughout 
the body and cause degranulation of the mast cells of the connective tissue that are associated 
with blood vessels, causing an anaphylactic syndrome with serious consequences such as 
systemic vasodilation associated with a great loss of pressure of all the blood vessels and 
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constriction of the airways. In some patients with IgE antibodies against penicillin, for example, 
administration of intravenous penicillin can cause anaphylactic shock and even death within 
minutes (Regueiro González, et al., 2010). 
The IgE response may occur following administration of any antigen, including vaccines. It is 
more likely to occur in vaccines containing traces of foetal bovine serum, gelatine or casein, 
which should always be taken into account when animals are vaccinated. The IgE response 
may also occur following drug administration, although most drug molecules are too small to 
be antigenic but they may bind to the host proteins and thus act as haptens. Allergies to many 
drugs have been reported in domestic animals, especially antibiotics and hormones (Tizard, 
2009). Even allergies can be caused to the substances used to preserve leather from harnesses, 
catgut sutures, compounds such as methylcelulose or carboxymethylcellulose used as 
stabilizer in vaccines and dextrans used as synthetic colloids in fluid therapy (Carrillo Poveda, 
et al., 2006).  
Allergies to parasites and other organisms 
Helminths  
Many studies have hypothesized that there is some relationship between the response 
generated against allergens and against some parasites such as helminths. Possibly, the IgE 
response to a certain antigen was initially developed to combat parasites against helminth 
parasites (Tizard, 2009). It has been suggested that the possible similarity with the molecular 
patterns that are recognized by the immune system in these parasites may favour such allergic 
responses against other allergens (Regueiro González, et al., 2010).  
Arthropods  
Allergies are also commonly associated with exposure to arthropod antigens. Insect bites 
cause many human deaths each year due to acute anaphylaxis following poison sensitization. 
In animals if an allergic reaction to saliva antigens is generated by these arthropods, an allergic 
dermatitis characterized by urticaria and intense pruritus may occur. This is the case of scabies 
by Sarcoptes scabiei in dogs and by Octodectes cyanotis in cats, whose allergy may contribute 
to the development of skin lesions. However, as we said at the beginning of the review, 
animals do not always respond to allergens with a Type I Hypersensitivity, but they can also 
respond by a Type IV Hypersensitivity reaction. Examples of Type IV Hypersensitivity reaction 
are the allergic response to Demodex and components of flea saliva. Flea Allergy Dermatitis 
 . 
 
24 
TYPE I HIPERSENSITIVITY REACTION IN THE CANINE SPECIES 
Canine Atopic Dermatitis and other allergic diseases   
(FAD) is one of the most important allergic skin diseases in veterinary medicine. There is no 
racial or sex predisposition, but atopic animals, as well as those exposed intermittently to 
fleas, tend to present a more serious disease, while continued exposure to fleas at an early age 
seems to result in a form of hyposensitization  (Dryden & Rust, 1994; Guaguere, et al., 2008; 
Tizard, 2009). 
In addition to the importance of FAD, in Europe (Italy, France, Spain, Belgium, and the 
Netherlands) the processionary caterpillar (Thaumatopoea processionea) is an increasing cause 
of urticaria, angioedema, or even anaphylactic reaction. Each caterpillar has approximately 
700.000 to one million of hairs, which contain substance responsible for the acute contact 
reaction after touching skin and mucosa (Miller & Willemse, 1997; Bonamonte, et al., 2013).  
2.1. Clinical approach of the allergic patient: diagnostic and therapeutic tools  
Effective management of allergic diseases relies on the ability to make an accurate diagnosis. 
Allergy testing can help, confirm or rule out allergies (Portnoy & Amado, 2006). A correct 
clinical approach of the patient, combining allergy testing and allergen avoidance, reduces the 
incidence of symptoms and need for medications, and improves quality of life. Nevertheless, 
the use of drugs and allergen immunotherapy will continue to be necessary in many cases of 
allergen since the complete avoidance of the allergen is very complicated and not always 
practical (NHS, 2016).  
It seems reasonable to think that each allergy must be diagnosed with disparate methods. 
However, the diagnosis of different allergic diseases is often similar or even identical. Instead, 
the therapeutic guidelines will differ depending on the patient's symptoms. 
DIAGNOSIS 
HISTORY AND CLINICAL DIAGNOSIS 
Contrary to a far too widely held belief, diagnosis of allergic diseases is not based solely on the 
results of allergy testing. Allergy test results should only be interpreted in the light of 
appropriate history and clinical signs. About 20-30% of atopic dogs produce negative allergy 
test results whereas a similar or even greater percentage (<50%) of normal dogs may test 
positive (Codner & Tinker, 1995). 
In addition to the data collected during the anamnesis (age, sex, breed, etc.), most important 
questions to ask to the owner relate to diet, stools, in-contact animals, habitat, itchy score, 
 . 
 
25 
TYPE I HIPERSENSITIVITY REACTION IN THE CANINE SPECIES 
Canine Atopic Dermatitis and other allergic diseases   
seasonal variation and changes when the animal is taken to another location (Guaguere, et al., 
2008). Moreover, an elimination diet must be carried out and followed strictly at the beginning 
of the clinical approach of chronic and repetitive pictures. A third of atopic dogs can be 
controlled with diet but compliance is not always perfect (Chesney, 2002). A dietary history 
must be taken and all items listed and that is not easy given the abundance of food sources.  
ALLERGY TESTING: SEROLOGICAL AND INTRADERMAL TESTING 
Allergy tests are not usually done in cases of spontaneous allergies (e.g., allergic reaction to 
insect bites, spontaneous urticaria, etc.), but they are usually performed in cases of chronic 
allergies in atopic dogs, such as dogs with CAD. Once a clinical diagnosis of allergy is made, 
allergy test can be performed to identify potential causative allergens for allergen-specific 
immunotherapy (Hensel, et al., 2015). Allergy testing is more focused on the identification of 
aeroallergens.  
There are two basic types of allergy testing: serological testing and intradermal skin testing. 
Serological methods of measuring the level of specific IgE in body fluids include the RAST 
(radioallergosorbent test), ELISA test (enzyme-linked immunosorbent essay) and FEIA 
(Fluorescent enzyme immunoassay) (Tizard, 2013). Intradermal skin testing is the other type of 
allergy testing especially used for the diagnosis of CAD (Tizard, 2013). Each method has pros 
and cons (Foster & Smith, 1995) and even though both are recommended due to their similar 
diagnostic value (Boyce, 2010; Cox, 2011), there are poor correlation between the results 
obtained by serology or skin testing. The reason for this poor correlation between direct IgE 
measurements and in vivo methods are debatable but probably reflect the fact that the skin 
microenvironment is much more complex than in the bloodstream. For these reasons many 
veterinary dermatologists prefer skin testing (Tizard, 2013).  
Another type of test can also be performed in cases of suspected food allergy in which it was 
not possible to identify the food that causes the allergy through an elimination diet. These 
quick tests, whose effectiveness is not evaluated in this review, have recently been developed 
and are based on the detection of IgA and IgM in the dog's saliva. The mission is to help 
establish a hypoallergenic diet suitable for the patient (Dodds, 2013). In the case that this kind 
of test is to be applied, as with allergy tests, a detailed medical history must always be made.  
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TREATMENT AND MANAGEMENT  
Management of allergies typically involves avoiding what triggers the allergy, routine measures 
and medications to improve the symptoms. Allergen immunotherapy may be useful for some 
types of allergies (Anon., 2015). 
AVOIDING EXPOSURE TO ALLERGENS 
The best way to prevent an allergic reaction is to avoid the substance that the animal is allergic 
to, although this is not always easy (NHS, 2016). A hypoallergenic diet can be continued 
beyond the time needed to diagnose food hypersensitivity but the possibility of the patient 
developing hypersensitivity to an item in the hypoallergenic diet cannot be discounted. 
Aeroallergens avoidance concerns mainly house dust mites and for it be effective, the mites 
must be killed or have their life cycle broken. In addition, proteins in their cuticle and faeces 
must be denatured (Guaguere, et al., 2008). 
ROUTINE MEASURES 
Certain simple steps can significantly reduce the development of allergies. Particularly in CAD 
the clinician has to take into account that the condition is multifactorial. Basic hygiene 
measures (flea control, feeding a well-balanced diet, use of shampoos, emollients and topical 
ear products, grooming, etc.) applicable to every atopic dog, will control pruritus lesions in 
most mild cases and reduce the need for drugs in more serious cases (Guaguere, et al., 2008).  
MEDICATIONS 
It is difficult to consider a classification of all drugs used in practice to combat allergies. 
However, special mention can be made of those current medications which are most 
frequently used to treat allergic symptoms (Table 3).  
Table 3. Most commonly used medications for the treatment of allergies in dogs    
Pharmacological 
group 
Purpose or use  Indications* Considerations   
Topic anti-inflammatory agents 
Glucocorticoids  Topical steroids can be 
used in hairless areas for 
well-circumscribed non-
infected lesions due to 
allergic reactions.  
Canine Atopic 
Dermatitis 
Allergic dermatitis 
Allergic blepharitis   
Allergic 
conjunctivitis  
 
Hairy coat limits 
their usefulness. 
Topical 
glucocorticoids can 
be effective and 
well tolerated but 
are not suitable for 
generalized pruritus 
due to CAD.  
(Guaguere & 
Bansignor, 2002; 
Guaguere, et al., 
2008; Morgan, 
2008; Cosgrove, 
et al., 2013) 
 . 
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Tacrolimus A 0.1% tacrolimus gel can 
be used to bring about a 
significant reduction in 
lesion severity  
Canine Atopic 
Dermatitis  
When treatment is 
first started, 
irritation may 
increase  
(Marsella, et al., 
2004; Guaguere, 
et al., 2008) 
Other topical 
agents 
(glycerine, 
chlorhexidine, 
piroctone 
olamine, 
analgesics, 
antihistamines, 
essential fatty 
acids, vitamin E, 
anti-pruritic 
agents)  
Depending on the agent, 
one or other objective is 
pursued  
Canine Atopic 
Dermatitis  
Allergic 
conjunctivitis 
Allergic blepharitis  
These topical 
agents have to be 
used very 
frequently (daily) 
for benefit to be 
obtained  
(Guaguere, et al., 
2008; Morgan, 
2008) 
Systemic treatments 
Glucocorticoids 
(prednisone, 
prednisolone, 
methylprednisol
one, fluticasone, 
etc.)  
Glucocorticoids are 
potent anti-
inflammatories. They 
supress cyclooxygenase 
expression and inhibits 
prostaglandins and 
leukotrienes.   
Canine Atopic 
Dermatitis 
Anaphylactic shock 
Urticaria and 
angioedema (Table 
4)  
Allergic bronchitis  
For prolonged 
treatment (CAD), a 
minimum effective 
dose must be 
sought. They are 
highly effective, but 
adverse effects are 
common so regular 
monitoring is 
essential 
Short-term 
administration of 
corticosteroids may 
be warranted to 
decrease airway 
inflammation in 
severe case of 
bronchitis.  
(Dhupa, 2005; 
Guaguere, et al., 
2008; Morgan, 
2008; Cosgrove, 
et al., 2013; 
Anon., 2015)  
Antihistamines 
(amitriptyline, 
astemizole, 
cetrizine, 
chlorpheniramin
e, clocinizine, 
cyproheptadine, 
dexachlorphenir
amine, 
diphenydramine
, mydroxyzine, 
loratadine, 
mequitazine and 
promethazine)  
Antihistamines oppose 
the activity of histamine 
receptors (H1 and H2) in 
the body. The role of H2-
Antihistamines, such as 
ranitidine, in the 
treatment of allergic 
conditions is less clear 
than H1-Antihistamines.  
Night time pruritus 
(for anxiolytic 
activity of first 
generation 
antihistamines)  
Urticaria and 
angioedema (Table 
4) 
Anaphylaxis  
Canine Atopic 
Dermatitis 
(responses to 
antihistamines in 
dogs with CAD are 
unpredictable) 
Allergic blepharitis  
 
H1-Antihistamines 
are commonly used, 
both as single 
agents, and as 
synergistic 
medications used to 
reduce required 
dosage of 
glucocorticoids.  
 
(Olivry & Mueller, 
2003; Cook, et 
al., 2004; 
Morgan, 2008; 
Guaguere, et al., 
2008; Kupczyk, et 
al., 2008; 
Canoninca & 
Blaiss, 2011; 
Fragio, 2011)  
Epinephrine Stimulation of alpha 
adrenoceptors improves 
blood pressure and 
coronary perfusion; 
stimulation of beta-1 
adrenoceptor has both 
positive inotropic and 
chronotropic cardiac 
effects; stimulation of 
beta-2 adrenoceptors 
Anaphylaxis (first 
line treatment) 
In anaphylactic 
shock, epinephrine 
is best administered 
either 
intramuscularly or 
as an intravenous 
constant rate 
infusion. Bolus 
administration of IV 
epinephrine has 
(Dhupa, 2005; 
Fragio, 2011) 
 . 
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causes and reduces the 
release of inflammatory 
mediators  
been associated 
with the induction 
of fatal cardiac 
arrhythmias and 
myocardial 
infarction.  
Bronchodilators 
(Beta-2 agonists: 
albuterol and 
terbutaline, 
methylxantines 
derivatives: 
theophylline and 
aminophylline,  
and 
anticholinergics: 
atropine and 
ipratropium 
bromide)  
The purpose is the 
dilatation of the bronchi 
and bronchioles, 
decreasing resistance in 
the respiratory airway 
and increasing airflow to 
the lungs. In the case of 
anticholinergic drugs, 
they relax airway smooth 
muscle and reduce mucus 
production through 
blockage of vagal nerve 
transmission to airway 
smooth muscle and 
submucosal gland and 
globet cells.  
Allergic bronchitis 
(canine chronic 
bronchitis)  
Beta-2 agonists and 
methylxanthine 
derivatives seem to 
act synergistically 
with glucocorticoids 
to control airway 
inflammation. 
Anticholinergics are 
widely used for the 
treatment of COPD 
in humans, but it 
has not proven to 
be an effective 
bronchodilator in 
dogs.  
(King, 2004; 
Gosens, et al., 
2006; Tilley, 
2010)  
Cough 
suppressants 
(antitussives) 
(dextromethorp
han, codeine, 
buthorphanol, 
hydrocodone, 
etc.)  
Depending on the agent, 
the mechanisms by which 
it acts is different.  
Prolonged or 
exhausting non-
productive coughs 
in Allergic 
bronchitis (canine 
chronic bronchitis)  
Cough suppressants 
are not used if the 
cough is productive, 
or if the 
transtracheal wash 
suggests infection   
(King, 2004; 
Anon., 2015; 
Morgan, 2008) 
Cyclosporin A Cyclosporin A inhibits the 
activation of cells capable 
of inducing (T 
lymphocytes and 
Langerhans’s cells) and 
effecting (mast cells and 
eosinophils) the allergic 
inflammatory response  
Canine Atopic 
Dermatitis  
Allergic blepharitis  
Cyclosporin A can 
effectively control 
atopic dermatitis, 
but the delayed 
onset of action 
makes it impractical 
as a stand-alone 
therapy for the 
rapid management 
of pruritus. 
However, at two 
weeks of treatment, 
its efficacy is 
comparable to that 
of glucocorticoids. 
 (Guaguere, et al., 
2004; Guaguere, 
et al., 2004; 
Guaguere, et al., 
2008; Morgan, 
2008; Cosgrove, 
et al., 2013)  
Anti-pruritics 
(Oclacitinib, 
Canine Atopic 
Dermatitis 
Immunotherape
utic CADI)  
The treatment of pruritic 
dogs has the following 
two goals: to reduce or 
eliminate the pruritus, 
which breaks the itch 
cycle, allowing the skin to 
heal, preventing chronic 
inflammatory changes 
and secondary infection, 
and reducing patient and 
owner discomfort and 
distress; and to diagnose 
and manage the cause of 
the pruritus. 
Canine Atopic 
Dermatitis (Table 5)  
Allergic dermatitis 
and other pruritic 
skin diseases (with 
pruritic 
component).  
These drugs reduce 
highly effective 
pruritus but it has 
to take into account 
that they are not 
anti-inflammatory 
but only takes away 
signs of itchiness, so 
the dog still need to 
be appropriately 
treated with 
medications as 
needed to control 
the atopy.- 
(Cosgrove, et al., 
2013; Zoetis, 
2013; Zoetis, 
2017; Lee, 2017) 
Antimicrobial treatments 
Antibiotics  Depending on the agent, 
the mechanisms by which 
Bacterial 
proliferation 
Antibiotherapy 
ideally based on 
(King, 2004; 
Anon., 2015; 
 . 
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it acts is different. syndrome and 
associated 
pyoderma due to 
CAD  
Secondary 
infections due to 
allergic bronchitis, 
allergic blepharitis 
and conjunctivitis.   
culture and 
sensitivity testing   
 
Guaguere, et al., 
2008; Morgan, 
2008) 
Antifungals  
(ketoconazlole, 
itraconazole, 
posaconazole)  
Depending on the agent, 
the mechanisms by which 
it acts is different. 
Malassezia 
dermatitis due to 
CAD  
 (Guaguere, et al., 
2008) 
* According to the use of these medications, it is important to say that each patient has to be treated individually 
and, if necessary, make use of other medical tools such as oxygen therapy or fluid therapy, especially in acute 
allergic reactions (anaphylaxis) with life-compromising outcomes (Dhupa, 2005).  
Table 4. Proposed treatment plan for urticaria and angioedema in a Cocker Spaniel, castrated male, 7 years old 
(Emergencias Veterinarias de Zaragoza EMVET, Zaragoza-Spain, 2017).  
In the first place, the cause should be eliminated if known. However, many times the cause of urticaria and 
angioedema will be unknown. In this case, the process was related to a walk in the park 10 minutes before the 
reaction occurred but the exact cause was unknown. The patient had facial angioedema and erythematous rashes 
on the skin of the abdominal area. Airways were not compromised.  
Antihistamines 
- Diphenhydramine (Syva®) 0.5-1 mg/kg IM 
- Ranitidine: 1-2 mg/kg SC  
Glucocorticoids 
- Methylprednisolone (Urbason®) 1 mg/kg IM 
After the administration of drugs and discharge the patient, owners are advised to keep an eye on the animal, in 
search of relapses or clinical signs that could occur as a consequence of the late phase of the allergic reaction: 
vomits, diarrhea, etc.  
 
Table 5. Proposed treatment plan for Canine Atopic Dermatitis (CAD) with secondary skin infection (Malassezia 
spp.) in a French Bulldog, neutered female, 1 year 2 months old (Department of Dermatology of the Veterinary 
Hospital of Ghent University (Faculteit Diergeneeskunde), Ghent-Belgium, 2016).  
The patient, already diagnosed of CAD, needs veterinary assistance because of an intense itching episode. Since 
she is diagnosed, she takes a hypoallergenic diet. She has been taking prednisolone orally during 4 weeks but 1 
week ago corticotherapy has ended. During the treatment with steroids the itching was controlled (steroid 
responsive) but after stopping prednisolone dosage, pruritus has appeared again, especially on the legs and around 
the mouth. The patient often shakes her head and the right ear is painful. An ear swab is performed and a 
considerable amount of Malassezia spp. is detected (Malassezia otitis).  
Anti-pruritic drugs: 
- Oclacitinib (Apoquel®): 0.4-0.6 mg/kg PO daily during 4 weeks (allergy testing will be performed if itching is 
not gone during these 4 weeks) 
Treatment for Malassezia otitis due to CAD: 
- Orbifloxacin, mometasone furoate and posaconazole (Posatex otic suspension®)  
 
ALLERGEN-SPECIFIC IMMUNOTHERAPY (DESENSITISATION THERAPY) 
Allergies may be controlled by allergen-specific immunotherapy; particularly it is indicated 
whenever allergen avoidance does not produce significant improvement; only aeroallergens 
are indicated. Desensitisation therapy involves the regular subcutaneous injections of allergic 
extracts to which the animal is allergic. Allergen selection is based on allergy test results, 
intradermal or in vitro (Guaguere, et al., 2008). The best results are obtained with mite and 
 . 
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pollen extracts. Insect, epithelia and mould spore extracts have not been found to give good 
results. The number of allergens to which the animal is sensitised is not a significant prognostic 
factor (Griffin & Hiller, 2001; Zur & White, 2002).  
Multiple controlled studies have shown that this therapy is effective in humans. It appears to 
be most effective for the treatment of allergic rhinitis (hay fever), asthma, and allergies to 
insect stings. However, there is often an element of confusion with regard to the definition of 
improvement or success of allergen-specific immunotherapy in the treatment of food allergies 
and allergic dermatitis.  In veterinary medicine multiple open studies have suggested that this 
therapy is effective in the treatment of atopic dermatitis (Tizard, 2013), although few 
randomized controlled trials have been published. It has been estimated that up to 80% of 
dogs have a good to excellent response to this procedure (Griffin & Hiller, 2001; Tizard, 2013). 
The improvement may take the form of longer intervals between flares, a less extensive 
distribution, reduced lesion severity or a marked reduction in drug consumption.   
Immunologic changes that occur during allergen-specific immunotherapy are complex and not 
completely understood. However, successful immunotherapy has been associated with a shift 
from T helper cell type-2 (Th2) immune responses, which are associated with the development 
of atopic conditions, to Th1 immune responses (Shida, et al., 2004; Moote & Kim, 2011). It is 
also associated with the production of T regulatory cells that produce the anti-inflammatory 
cytokine, interleukin 10 (IL-10), amongst others such as transforming growth factor (TGF) -
beta. IL-10 has been shown to reduce levels of allergen-specific immunoglobulin E (IgE) 
antibodies, increase levels of immunoglobulin G (IgG) (blocking) antibodies that play a role in 
secondary immune responses, and reduces the release of pro-inflammatory cytokines from 
mast cells, eosinophils and T cells. Allergen-specific immunotherapy has also been found to 
decrease the recruitment of mast cells, basophils, and eosinophils to the skin, nose, eye, and 
bronchial mucosa after exposure to allergens, and reduces the release of mediators, such as 
histamine, from basophils and mast cells (Cox, et al., 2008; Frew, 2010).  
3. CONCLUSIONES/ CONCLUSIONS 
Español:  
1. El conocimiento completo de los procesos inmunológicos que acontecen en la reacción 
de hipersensibilidad de tipo I es esencial para abordar clínicamente con éxito a un 
paciente alérgico, evitando confusiones cuando se aborda un proceso de 
hipersensibilidad determinado en la especie canina.  
 . 
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2. La hipersensibilidad inmediata es un trastorno del sistema inmunológico en el cual 
intervienen varios factores (tanto intrínsecos al animal como extrínsecos) y, aunque las 
pautas de diagnóstico a menudo son similares, será necesario conocer todas las 
herramientas terapéuticas para poder establecer un tratamiento adecuado para cada 
condición.  
3. En la especie canina, la Dermatitis Atópica Canina (CAD) lleva el término "alergia" a su 
máxima expresión, siendo un síndrome multifactorial que nos permite estudiar las 
evidencias que explican la razón por la cual un perro es alérgico y por qué manifiesta 
un cuadro clínico tan característico.   
English:  
1. The full knowledge of the immunology of Type I Hypersensitivity reaction is essential 
to successfully approach clinically an allergic patient, avoiding misunderstandings 
when we are talking about different processes of hypersensitivity in the canine 
species.  
2. Immediate hypersensitivity is a disorder of the immune system in which several factors 
figure (both intrinsic to the animal and extrinsic) and, although the diagnostic 
guidelines will often be similar, it will be necessary to know all the therapeutic tools to 
be able to establish a suitable treatment for each allergic condition. 
3. In the canine species, Canine Atopic Dermatitis (CAD) represents the term 'allergy' with 
its maximum expression, being a multifactorial syndrome which enable us to study the 
evidences that explain the reason why a dog is allergic and why they manifest such a 
typical symptomatology in practice.  
 
4. PERSONAL VALUATION 
The decision to choose a topic for my final degree thesis closely related to the allergy reaction 
was not arbitrary. From the age of 10 the allergy accompanies me almost daily to all over the 
places where I go. It was during my first year of studies at CEU Cardenal Herrera University 
when the Professor Maria Isabel Guillén began to explain the lesson of hypersensitivity and 
allergies. At that moment, apart from feeling identified with everything she was explaining, I 
was fascinated to know how the immune system of animals works. Throughout my career as a 
veterinary student I have not only felt attracted to immunology, but I have also done so by 
pharmacology. Doing this review on allergies, it has allowed me to put into practice and 
deepen on much knowledge of immunology and pharmacology. In addition, find out what 
 . 
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other have studies and researched about allergies has allowed me to improve my ability to 
analyze different sources of information.  This all has been really successful for me and my 
career.  
Once this work is almost completed, I would like to highlight that I still have the desire to go 
deeper into some aspects that have been treated. Topics such as the hygiene hypothesis - 
could it really apply in a certain way to the canine species?, and issues relating the influence of 
platelets in the allergic reaction - do they play a more important role than we realize?. In 
addition, it would be interesting to know more about allergen-specific immunotherapy, and 
fortunately researches surrounding the mechanisms of this therapy are still ongoing and will 
help further elucidate how this therapy exerts its beneficial effects in allergic diseases. Perhaps 
in a near future I will be able to resume this review with more force and time. 
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